UNH Valuation Back in Focus After Earnings Beat

UnitedHealth Group (UNH) recently reported its Q2 2026 results, exceeding revenue and adjusted EPS forecasts. The company also provided improved adjusted operating margin due to lower medical costs.

The insurer's shares have cooled down in the past month with a 30-day return of -5.48%, yet they still show positive momentum year-to-date with a 20.57% return and 1-year total shareholder return of 53.21%. However, long-term returns are more muted at 3 and 5 years.

The narrative suggests that the stock is currently overvalued by 2.7%, trading at $405.59. A discounted cash flow model provided a different picture, indicating that UNH trades at a 55.1% discount to an estimated future cash flow value of $903.47.